A range of harmonisation studies of PD-L1 assays were performed, showing that while the estimation of PD-L1 expression in tumour cells was consistent among pathologists, the concordance in the assessment of PD-L1 in immune cells was poor [14,15,16,17,18,19,20,21]. The gene discussed is CD274; the disease is neoplasm.